Person · CIK 1336504

Ian T Clark

Director at Guardant Health, Olema Pharmaceuticals, Corvus Pharmaceuticals, Biomarin Pharmaceutical, Kyverna Therapeutics, GoodRx Holdings and Takeda Pharmaceutical

Earlier: AVROBIO, Agios Pharmaceuticals, Forty Seven, Kite Pharma, TerraVia Holdings, Dendreon and Genentech

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$45.2M

Noticed on Form 144$14.6M

Bought on Form 4$54K

Companies14

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Guardant Health GH	Common Stock	By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	2,975	Aug 4, 2026 · Filing · EDGAR
Olema Pharmaceuticals OLMA	Stock Option (right to buy) exercise $9.51, expires Jun 18, 2036, into Common Stock	Directly	29,500	Jun 18, 2026 · Filing · EDGAR
Corvus Pharmaceuticals CRVS	Stock Option (Right to Buy) exercise $11.60, expires Jun 11, 2036, into Common Stock	Directly	15,000	Jun 11, 2026 · Filing · EDGAR
Biomarin Pharmaceutical BMRN	Common Stock	Directly	14,490	Jun 2, 2026 · Filing · EDGAR
Kyverna Therapeutics KYTX	Common Stock	Directly	21,727	May 27, 2026 · Filing · EDGAR
Kyverna Therapeutics KYTX	Stock Option (right to buy) exercise $8.59, expires May 27, 2036, into Common Stock	Directly	20,582	May 27, 2026 · Filing · EDGAR
Takeda Pharmaceutical TAK	Ordinary Shares	Directly	9,700	Mar 18, 2026 · Filing · EDGAR
Takeda Pharmaceutical TAK	American Depositary Shares	Directly	9,696	Mar 18, 2026 · Filing · EDGAR
Takeda Pharmaceutical TAK	Cash Settled Retirement Award into Ordinary Shares	Directly	2,356	Mar 18, 2026 · Filing · EDGAR
Takeda Pharmaceutical TAK	Tax Obligation Award expires Jun 1, 2027, into Ordinary Shares	Directly	1,192	Mar 18, 2026 · Filing · EDGAR
Takeda Pharmaceutical TAK	Tax Obligation Award expires Jun 1, 2028, into Ordinary Shares	Directly	1,180	Mar 18, 2026 · Filing · EDGAR
GoodRx Holdings GDRX	Class A Common Stock	Directly	100,150	Jul 8, 2025 · Filing · EDGAR
GoodRx Holdings GDRX	Restricted Stock Unit into Class A Common Stock	Directly	34,497	Jul 8, 2025 · Filing · EDGAR
AVROBIO	Stock Option (Right to Buy) exercise $1.09, expires Jun 5, 2033, into Common Stock	Directly	17,643	Jun 6, 2023 · Filing · EDGAR
Agios Pharmaceuticals	Common stock	Directly	6,549	May 20, 2022 · Filing · EDGAR
TerraVia Holdings	Common Stock	Directly	3,000	Jun 2, 2011 · Filing · EDGAR
TerraVia Holdings	Stock Option (right to buy) expires May 21, 2027, into Common Stock	Directly	32,000	May 22, 2017 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)	Bought (Form 4)
Q3 2026	$2.3M	$2.3M	—
Q2 2026	$735K	$847K	—
Q4 2025	$10.9M	$10.9M	—
Q2 2025	$323K	$323K	—
Q4 2024	$245K	$245K	—
Q3 2021	$140K	Not machine-readable	—
Q2 2021	$1.5M	Not machine-readable	—
Q1 2021	$589K	Not machine-readable	—
Q4 2020	$1.1M	Not machine-readable	—
Q3 2020	$873K	Not machine-readable	—
Q2 2020	$756K	Not machine-readable	—
Q1 2020	$748K	Not machine-readable	—
Q4 2019	$701K	Not machine-readable	—
Q3 2019	$1.2M	Not machine-readable	—
Q2 2019	$6.3M	Not machine-readable	—
Q2 2011	—	—	$54K
Q3 2010	$281K	Not machine-readable	—
Q2 2010	$478K	Not machine-readable	—
Q3 2008	$8.2M	Not machine-readable	—
Q1 2008	$536K	Not machine-readable	—
Q1 2007	$3.1M	Not machine-readable	—
Q4 2005	$3.9M	Not machine-readable	—
Q3 2005	$397K	Not machine-readable	—

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Guardant Health GH · Charles Schwab · No 10b5-1 plan stated · 5 notices
Aug 4, 2026	14,180 · ~$2.3M	Aug 4, 2026	Sold as noticed Sold 14,180 in 2 sales, Aug 4 to Aug 4 · $2.3M Form 4	Filing · EDGAR
May 20, 2026	6,876 · ~$735K	May 20, 2026	Sold as noticed Sold 6,876 at $106.90 on May 20 · $735K Form 4	Filing · EDGAR
Dec 5, 2025	28,611 · ~$3.1M	Dec 5, 2025	Sold as noticed Sold 28,611 in 3 sales, Dec 5 to Dec 5 · $3.1M Form 4	Filing · EDGAR
Jun 17, 2025	6,672 · ~$323K	Jun 17, 2025	Sold as noticed Sold 6,672 at $48.38 on Jun 17 · $323K Form 4	Filing · EDGAR
Nov 12, 2024	8,318 · ~$245K	Nov 12, 2024	Sold as noticed Sold 8,318 in 2 sales, Nov 12 to Nov 12 · $245K Form 4	Filing · EDGAR
GoodRx Holdings GDRX · Morgan Stanley Smith Barney · No 10b5-1 plan stated · 1 notice
May 13, 2026	43,100 · ~$112K	May 13, 2026	Not sold within 90 days	Filing · EDGAR
Olema Pharmaceuticals OLMA · Fidelity Brokerage Services · No 10b5-1 plan stated · 1 notice
Dec 19, 2025	264,800 · ~$7.9M	Dec 19, 2025	Sold as noticed Sold 264,800 in 3 sales, Dec 19 to Dec 19 · $7.9M Form 4	Filing · EDGAR
Sales without a matching Form 144 · 178 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 1,076 at $130.00 on Sep 1, 2021 · $140K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 10,559 at $130.00 on Jun 29, 2021 · $1.4M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $159.92 on Apr 26, 2021 · $86K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $132.09 on Mar 25, 2021 · $71K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $154.00 on Feb 25, 2021 · $83K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $162.00 on Jan 25, 2021 · $87K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $129.23 on Jan 4, 2021 · $348K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $135.00 on Dec 28, 2020 · $73K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $120.00 on Dec 3, 2020 · $323K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $113.28 on Nov 25, 2020 · $61K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $105.28 on Nov 3, 2020 · $283K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $104.03 on Oct 26, 2020 · $56K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $108.50 on Oct 5, 2020 · $292K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $106.24 on Sep 25, 2020 · $57K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 1,136 at $90.54 on Sep 8, 2020 · $103K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,747 at $89.78 on Sep 8, 2020 · $247K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 5,263 at $88.69 on Sep 8, 2020 · $467K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $81.27 on Jun 25, 2020 · $44K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $87.52 on Jun 3, 2020 · $235K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $98.50 on May 26, 2020 · $53K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $72.17 on May 4, 2020 · $194K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $77.50 on Apr 27, 2020 · $42K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,689 at $70.00 on Apr 14, 2020 · $188K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $70.00 on Mar 25, 2020 · $38K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $78.33 on Mar 3, 2020 · $211K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $80.00 on Feb 25, 2020 · $43K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $76.23 on Feb 3, 2020 · $205K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $77.31 on Jan 27, 2020 · $42K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $77.87 on Jan 3, 2020 · $209K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $82.69 on Dec 26, 2019 · $44K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $72.78 on Dec 3, 2019 · $196K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $78.17 on Nov 25, 2019 · $42K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $71.82 on Nov 4, 2019 · $193K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 3,228 at $70.00 on Oct 28, 2019 · $226K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $72.00 on Sep 25, 2019 · $39K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $85.70 on Sep 3, 2019 · $231K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $94.05 on Aug 26, 2019 · $51K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 3,013 at $90.30 on Aug 6, 2019 · $272K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 5,706 at $89.71 on Aug 6, 2019 · $512K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 964 at $88.30 on Aug 6, 2019 · $85K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 2,690 at $65.91 on May 3, 2019 · $177K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 538 at $65.11 on Apr 25, 2019 · $35K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Guardant Health (GH): Sold 81,772 at $73.90 on Apr 15, 2019 · $6M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Dendreon: Sold 7,500 at $37.46 on Aug 20, 2010 · $281K	Filing · EDGAR
—	—	—	Notice not machine-readable Dendreon: Sold 8,744 at $54.61 on May 3, 2010 · $478K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $80.47 on Jul 16, 2008 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,600 at $80.43 on Jul 16, 2008 · $129K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 600 at $80.42 on Jul 16, 2008 · $48K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,400 at $80.41 on Jul 16, 2008 · $113K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,700 at $80.40 on Jul 16, 2008 · $217K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,380 at $80.38 on Jul 16, 2008 · $191K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 3,028 at $80.37 on Jul 16, 2008 · $243K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 200 at $80.36 on Jul 16, 2008 · $16K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,509 at $80.35 on Jul 16, 2008 · $121K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,600 at $80.34 on Jul 16, 2008 · $129K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 7,700 at $80.33 on Jul 16, 2008 · $619K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,700 at $80.32 on Jul 16, 2008 · $217K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,700 at $80.31 on Jul 16, 2008 · $217K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,600 at $80.30 on Jul 16, 2008 · $209K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,400 at $80.28 on Jul 16, 2008 · $112K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $80.26 on Jul 16, 2008 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 200 at $80.25 on Jul 16, 2008 · $16K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,700 at $80.24 on Jul 16, 2008 · $136K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 600 at $80.23 on Jul 16, 2008 · $48K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,400 at $80.21 on Jul 16, 2008 · $112K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,400 at $80.20 on Jul 16, 2008 · $112K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,700 at $80.19 on Jul 16, 2008 · $136K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 600 at $80.18 on Jul 16, 2008 · $48K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,600 at $80.16 on Jul 16, 2008 · $128K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $80.15 on Jul 16, 2008 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 4,300 at $80.14 on Jul 16, 2008 · $345K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 300 at $80.13 on Jul 16, 2008 · $24K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,200 at $80.11 on Jul 16, 2008 · $96K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,200 at $80.10 on Jul 16, 2008 · $96K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 300 at $80.09 on Jul 16, 2008 · $24K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,200 at $80.08 on Jul 16, 2008 · $176K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 400 at $80.05 on Jul 16, 2008 · $32K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 3,100 at $80.04 on Jul 16, 2008 · $248K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,505 at $80.03 on Jul 16, 2008 · $200K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 800 at $80.02 on Jul 16, 2008 · $64K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,600 at $80.01 on Jul 16, 2008 · $128K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $79.99 on Jul 16, 2008 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,600 at $79.98 on Jul 16, 2008 · $128K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 51 at $79.94 on Jul 16, 2008 · $4K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 81 at $79.93 on Jul 16, 2008 · $6K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 819 at $79.93 on Jul 16, 2008 · $65K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 500 at $79.92 on Jul 16, 2008 · $40K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $79.91 on Jul 16, 2008 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,600 at $79.90 on Jul 16, 2008 · $128K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,600 at $79.89 on Jul 16, 2008 · $128K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 983 at $79.88 on Jul 16, 2008 · $79K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 5,917 at $79.87 on Jul 16, 2008 · $473K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 900 at $79.86 on Jul 16, 2008 · $72K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 113 at $79.84 on Jul 16, 2008 · $9K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,500 at $79.81 on Jul 16, 2008 · $120K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $79.80 on Jul 16, 2008 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 3,500 at $79.79 on Jul 16, 2008 · $279K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $79.77 on Jul 16, 2008 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 800 at $79.76 on Jul 16, 2008 · $64K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 600 at $79.74 on Jul 16, 2008 · $48K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,100 at $79.73 on Jul 16, 2008 · $88K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,100 at $79.68 on Jul 16, 2008 · $88K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $79.67 on Jul 16, 2008 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,694 at $79.65 on Jul 16, 2008 · $135K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,205 at $79.64 on Jul 16, 2008 · $96K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,400 at $79.61 on Jul 16, 2008 · $111K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 300 at $79.60 on Jul 16, 2008 · $24K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 619 at $79.59 on Jul 16, 2008 · $49K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,900 at $79.57 on Jul 16, 2008 · $151K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 200 at $79.56 on Jul 16, 2008 · $16K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 700 at $79.52 on Jul 16, 2008 · $56K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 400 at $79.51 on Jul 16, 2008 · $32K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 4,800 at $79.50 on Jul 16, 2008 · $382K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,100 at $79.49 on Jul 16, 2008 · $167K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $79.48 on Jul 16, 2008 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,200 at $79.45 on Jul 16, 2008 · $175K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,100 at $79.44 on Jul 16, 2008 · $87K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $79.78 on Jul 16, 2008 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,000 at $79.43 on Jul 16, 2008 · $79K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 795 at $77.06 on Feb 27, 2008 · $61K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 6,167 at $77.00 on Feb 27, 2008 · $475K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 5,000 at $89.00 on Jan 19, 2007 · $445K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 5,000 at $88.00 on Jan 16, 2007 · $440K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 5,000 at $88.00 on Jan 16, 2007 · $440K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,900 at $87.25 on Jan 12, 2007 · $253K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,100 at $87.23 on Jan 12, 2007 · $96K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 200 at $87.19 on Jan 12, 2007 · $17K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 50 at $87.11 on Jan 12, 2007 · $4K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,500 at $87.07 on Jan 12, 2007 · $218K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $87.06 on Jan 12, 2007 · $9K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 4,900 at $87.05 on Jan 12, 2007 · $427K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 200 at $87.00 on Jan 12, 2007 · $17K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,900 at $86.99 on Jan 12, 2007 · $165K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 300 at $86.98 on Jan 12, 2007 · $26K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 250 at $86.97 on Jan 12, 2007 · $22K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,900 at $86.95 on Jan 12, 2007 · $252K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 200 at $86.93 on Jan 12, 2007 · $17K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 300 at $86.92 on Jan 12, 2007 · $26K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,100 at $86.91 on Jan 12, 2007 · $96K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 500 at $86.90 on Jan 12, 2007 · $43K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $86.87 on Jan 12, 2007 · $9K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $86.80 on Jan 12, 2007 · $9K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $86.77 on Jan 12, 2007 · $9K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $86.71 on Jan 12, 2007 · $9K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 200 at $86.70 on Jan 12, 2007 · $17K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 100 at $97.97 on Nov 23, 2005 · $10K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,879 at $97.95 on Nov 23, 2005 · $184K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 500 at $94.74 on Nov 14, 2005 · $47K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 183 at $94.58 on Nov 14, 2005 · $17K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 400 at $94.57 on Nov 14, 2005 · $38K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 500 at $94.35 on Nov 14, 2005 · $47K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,000 at $94.32 on Nov 14, 2005 · $94K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 500 at $93.94 on Nov 11, 2005 · $47K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 500 at $94.03 on Nov 11, 2005 · $47K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 375 at $94.06 on Nov 11, 2005 · $35K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 500 at $94.20 on Nov 11, 2005 · $47K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 627 at $93.02 on Nov 9, 2005 · $58K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 7,329 at $92.80 on Nov 9, 2005 · $680K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 200 at $92.90 on Nov 9, 2005 · $19K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 3,000 at $92.95 on Nov 9, 2005 · $279K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 700 at $93.02 on Nov 9, 2005 · $65K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,500 at $93.22 on Nov 9, 2005 · $140K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,000 at $93.32 on Nov 9, 2005 · $93K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 4,000 at $93.35 on Nov 9, 2005 · $373K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,500 at $93.40 on Nov 9, 2005 · $234K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 3,500 at $93.45 on Nov 9, 2005 · $327K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,000 at $93.46 on Nov 9, 2005 · $187K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,000 at $92.09 on Nov 2, 2005 · $92K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 500 at $92.01 on Nov 2, 2005 · $46K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 600 at $92.00 on Nov 2, 2005 · $55K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 817 at $91.99 on Nov 2, 2005 · $75K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 833 at $91.98 on Nov 2, 2005 · $77K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 3,167 at $91.98 on Nov 2, 2005 · $291K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,200 at $91.93 on Nov 2, 2005 · $110K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 800 at $91.92 on Nov 2, 2005 · $74K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 1,100 at $88.99 on Aug 19, 2005 · $98K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 775 at $88.98 on Aug 19, 2005 · $69K	Filing · EDGAR
—	—	—	Notice not machine-readable Genentech: Sold 2,583 at $88.98 on Aug 19, 2005 · $230K	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Guardant Health GH Director · filings 2018 to 2026 · sold $20.4M · $6.6M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 4, 2026	Option or RSU exercised or converted	+2,255	$91.11	$205K	10,322 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Aug 4, 2026	Option or RSU exercised or converted	+6,833	$50.57	$346K	17,155 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Aug 4, 2026	Open-market or private sale	−9,088	$158.98	$1.4M	8,067 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Aug 4, 2026	Open-market or private sale	−5,092	$158.80	$809K	2,975 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Aug 4, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−2,255			0 direct	Filing · EDGAR
Aug 4, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−6,833			0 direct	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted	+5,092			8,067 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted Restricted Stock Units	−5,092			0 direct	Filing · EDGAR
Jun 17, 2026	Grant or award from the company Restricted Stock Units	+2,711			2,711 direct	Filing · EDGAR
May 20, 2026	Open-market or private sale	−6,876	$106.90	$735K	2,975 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Dec 5, 2025	Option or RSU exercised or converted	+9,105	$38.42	$350K	18,956 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Dec 5, 2025	Option or RSU exercised or converted	+8,803	$38.01	$335K	27,759 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Dec 5, 2025	Option or RSU exercised or converted	+10,703	$31.84	$341K	38,462 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Dec 5, 2025	Open-market or private sale	−8,156	$106.67	$870K	30,306 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Dec 5, 2025	Open-market or private sale	−17,055	$107.27	$1.8M	13,251 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Dec 5, 2025	Open-market or private sale	−3,400	$108.05	$367K	9,851 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Dec 5, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−9,105			0 direct	Filing · EDGAR
Dec 5, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−8,803			0 direct	Filing · EDGAR
Dec 5, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−10,703			0 direct	Filing · EDGAR
Jun 18, 2025	Grant or award from the company Stock Option (Right to Buy)	+6,833			6,833 direct	Filing · EDGAR
Jun 18, 2025	Grant or award from the company Restricted Stock Units	+5,092			5,092 direct	Filing · EDGAR
Jun 17, 2025	Sale under a 10b5-1 plan	−6,672	$48.38	$323K	9,851 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Jun 12, 2025	Option or RSU exercised or converted	+8,088			16,523 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Jun 12, 2025	Option or RSU exercised or converted Restricted Stock Units	−8,088			0 direct	Filing · EDGAR
Nov 12, 2024	Option or RSU exercised or converted	+1,076	$4.18	$4K	16,753 direct	Filing · EDGAR
Nov 12, 2024	Open-market or private sale	−1,076	$29.52	$32K	15,677 direct	Filing · EDGAR
Nov 12, 2024	Open-market or private sale	−7,242	$29.44	$213K	8,435 direct	Filing · EDGAR
Nov 12, 2024	Other acquisition or disposition (see the filing)	−8,435			0 direct	Filing · EDGAR
Nov 12, 2024	Other acquisition or disposition (see the filing)	+8,435			8,435 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	Filing · EDGAR
Nov 12, 2024	Option or RSU exercised or converted Stock Option (Right to Buy)	−1,076			0 direct	Filing · EDGAR
Jun 12, 2024	Option or RSU exercised or converted	+6,776			15,677 direct	Filing · EDGAR
Jun 12, 2024	Option or RSU exercised or converted Restricted Stock Units	−6,776			0 direct	Filing · EDGAR
Jun 12, 2024	Grant or award from the company Stock Option (Right to Buy)	+10,703			10,703 direct	Filing · EDGAR
Jun 12, 2024	Grant or award from the company Restricted Stock Units	+8,088			8,088 direct	Filing · EDGAR
Jun 14, 2023	Option or RSU exercised or converted	+6,703			8,901 direct	Filing · EDGAR
Jun 14, 2023	Option or RSU exercised or converted RESTRICTED STOCK UNITS	−6,703			0 direct	Filing · EDGAR
Jun 14, 2023	Grant or award from the company STOCK OPTION (RIGHT TO BUY)	+8,803			8,803 direct	Filing · EDGAR
Jun 14, 2023	Grant or award from the company RESTRICTED STOCK UNITS	+6,776			6,776 direct	Filing · EDGAR
Jun 15, 2022	Option or RSU exercised or converted	+2,198			2,198 direct	Filing · EDGAR
Jun 15, 2022	Option or RSU exercised or converted RESTRICTED STOCK UNITS	−2,198			0 direct	Filing · EDGAR
Jun 15, 2022	Grant or award from the company STOCK OPTION (RIGHT TO BUY)	+8,789			8,789 direct	Filing · EDGAR
Jun 15, 2022	Grant or award from the company RESTRICTED STOCK UNITS	+6,703			6,703 direct	Filing · EDGAR
Sep 1, 2021	Option or RSU exercised or converted	+1,076	$4.18	$4K	1,076 direct	Filing · EDGAR
Sep 1, 2021	Sale under a 10b5-1 plan	−1,076	$130.00	$140K	0 direct	Filing · EDGAR
Sep 1, 2021	Option or RSU exercised or converted STOCK OPTION (RIGHT TO BUY)	−1,076			1,076 direct	Filing · EDGAR
Jun 29, 2021	Option or RSU exercised or converted	+1,076	$4.18	$4K	5,719 direct	Filing · EDGAR
Jun 29, 2021	Option or RSU exercised or converted	+4,840	$77.09	$373K	10,559 direct	Filing · EDGAR
Jun 29, 2021	Sale under a 10b5-1 plan	−10,559	$130.00	$1.4M	0 direct	Filing · EDGAR
Jun 29, 2021	Option or RSU exercised or converted STOCK OPTION (RIGHT TO BUY)	−1,076			2,152 direct	Filing · EDGAR
Jun 29, 2021	Option or RSU exercised or converted STOCK OPTION (RIGHT TO BUY)	−4,840			0 direct	Filing · EDGAR
Jun 16, 2021	Grant or award from the company STOCK OPTION (RIGHT TO BUY)	+3,135			3,135 direct	Filing · EDGAR
Jun 16, 2021	Grant or award from the company RESTRICTED STOCK UNITS	+2,198			2,198 direct	Filing · EDGAR
Apr 26, 2021	Option or RSU exercised or converted	+538	$4.18	$2K	5,181 direct	Filing · EDGAR
Apr 26, 2021	Sale under a 10b5-1 plan	−538	$159.92	$86K	4,643 direct	Filing · EDGAR
Apr 26, 2021	Option or RSU exercised or converted STOCK OPTION (RIGHT TO BUY)	−538			3,228 direct	Filing · EDGAR
Mar 25, 2021	Option or RSU exercised or converted	+538	$4.18	$2K	5,181 direct	Filing · EDGAR
Mar 25, 2021	Sale under a 10b5-1 plan	−538	$132.09	$71K	4,643 direct	Filing · EDGAR
Mar 25, 2021	Option or RSU exercised or converted STOCK OPTION (RIGHT TO BUY)	−538			3,766 direct	Filing · EDGAR
Feb 25, 2021	Option or RSU exercised or converted	+538	$4.18	$2K	5,181 direct	Filing · EDGAR
Feb 25, 2021	Sale under a 10b5-1 plan	−538	$154.00	$83K	4,643 direct	Filing · EDGAR

116 earlier transactions are in the filing list below.

Olema Pharmaceuticals OLMA Director · filings 2020 to 2026 · sold $7.9M · $7.9M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Jun 18, 2026	Grant or award from the company Stock Option (right to buy)	+29,500			29,500 direct	Filing · EDGAR
Dec 19, 2025	Option or RSU exercised or converted	+209,690	$4.41	$924K	209,690 direct	Filing · EDGAR
Dec 19, 2025	Option or RSU exercised or converted	+21,520	$3.61	$78K	231,210 direct	Filing · EDGAR
Dec 19, 2025	Option or RSU exercised or converted	+21,520	$7.84	$169K	252,730 direct	Filing · EDGAR
Dec 19, 2025	Option or RSU exercised or converted	+12,070	$4.08	$49K	264,800 direct	Filing · EDGAR
Dec 19, 2025	Open-market or private sale	−29,904	$28.83	$862K	234,896 direct	Filing · EDGAR
Dec 19, 2025	Open-market or private sale	−193,056	$29.71	$5.7M	41,840 direct	Filing · EDGAR
Dec 19, 2025	Open-market or private sale	−41,840	$30.48	$1.3M	0 direct	Filing · EDGAR
Dec 19, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−209,690			0 direct	Filing · EDGAR
Dec 19, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−21,520			0 direct	Filing · EDGAR
Dec 19, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−21,520			0 direct	Filing · EDGAR
Dec 19, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−12,070			12,080 direct	Filing · EDGAR
Jun 11, 2025	Grant or award from the company Stock Option (right to buy)	+24,150			24,150 direct	Filing · EDGAR
Jun 14, 2024	Grant or award from the company Stock Option (right to buy)	+23,000			23,000 direct	Filing · EDGAR
Jun 16, 2023	Grant or award from the company Stock Option (right to buy)	+21,520			21,520 direct	Filing · EDGAR
Jun 17, 2022	Grant or award from the company Stock Option (right to buy)	+21,520			21,520 direct	Filing · EDGAR
Jun 16, 2022	Grant or award from the company Stock Option (right to buy)	+21,520			21,520 direct	Filing · EDGAR
Jun 9, 2021	Grant or award from the company Stock Option (right to buy)	+21,520			21,520 direct	Filing · EDGAR
Nov 18, 2020	Grant or award from the company Stock Option (Right to Buy)	+21,520			21,520 direct	Filing · EDGAR
Aug 12, 2020	Grant or award from the company Stock Option (Right to Buy)	+209,690			209,690 direct	Filing · EDGAR

Corvus Pharmaceuticals CRVS Director · filings 2017 to 2026

Date	Transaction	Shares	Held after	Source
Jun 11, 2026	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 12, 2025	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 13, 2024	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Dec 6, 2023	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 15, 2023	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Aug 11, 2022	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 15, 2022	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Sep 9, 2021	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 15, 2021	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 9, 2020	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Mar 19, 2020	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 20, 2019	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 21, 2018	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jun 8, 2017	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR
Jan 3, 2017	Grant or award from the company Stock Option (Right to Buy)	+30,000	30,000 direct	Filing · EDGAR

Biomarin Pharmaceutical BMRN Director · filings 2025 to 2026

Date	Transaction	Shares	Price	Value	Held after	Source
Jun 2, 2026	Grant or award from the company	+7,490			14,490 direct	Filing · EDGAR
Aug 1, 2025	Grant or award from the company	+7,000			7,000 direct	Filing · EDGAR

Kyverna Therapeutics KYTX Director · filings 2024 to 2026

Date	Transaction	Shares	Held after	Source
May 27, 2026	Grant or award from the company	+5,093	21,727 direct	Filing · EDGAR
May 27, 2026	Grant or award from the company Stock Option (right to buy)	+20,582	20,582 direct	Filing · EDGAR
May 29, 2025	Grant or award from the company	+16,634	16,634 direct	Filing · EDGAR
May 29, 2025	Grant or award from the company Stock Option (right to buy)	+65,351	65,351 direct	Filing · EDGAR

GoodRx Holdings GDRX Director · filings 2024 to 2026 · $112K noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Jul 8, 2025	Option or RSU exercised or converted	+17,248	$4.74	$82K	100,150 direct	Filing · EDGAR
Jul 8, 2025	Option or RSU exercised or converted Restricted Stock Unit	−17,248			34,497 direct	Filing · EDGAR
Jun 3, 2025	Grant or award from the company	+57,050			82,902 direct	Filing · EDGAR
Jul 8, 2024	Grant or award from the company	+25,852			25,852 direct	Filing · EDGAR
Jul 8, 2024	Grant or award from the company Restricted Stock Unit	+51,745			51,745 direct	Filing · EDGAR

Takeda Pharmaceutical TAK Director · filings 2026 to 2026

No transactions in the filings read; Form 144 notices are listed above.

AVROBIO Director · filings 2018 to 2023

Date	Transaction	Shares	Held after	Source
Jun 6, 2023	Grant or award from the company Stock Option (Right to Buy)	+17,643	17,643 direct	Filing · EDGAR
Jun 8, 2022	Grant or award from the company Stock Option (Right to Buy)	+17,478	17,478 direct	Filing · EDGAR
Jun 8, 2022	Grant or award from the company Stock Option (Right to Buy)	+17,478	17,478 direct	Filing · EDGAR
Jun 10, 2021	Grant or award from the company Stock Option (Right to Buy)	+17,438	17,438 direct	Filing · EDGAR
Jun 4, 2020	Grant or award from the company Stock Option (Right to Buy)	+14,000	14,000 direct	Filing · EDGAR
Jun 11, 2019	Grant or award from the company Stock Option (Right to Buy)	+9,675	9,675 direct	Filing · EDGAR

Agios Pharmaceuticals Director · filings 2017 to 2022

Date	Transaction	Shares	Held after	Source
May 20, 2022	Option or RSU exercised or converted	+1,585	6,549 direct	Filing · EDGAR
May 20, 2022	Option or RSU exercised or converted Restricted stock unit	−1,585	0 direct	Filing · EDGAR
May 28, 2021	Option or RSU exercised or converted	+1,686	4,964 direct	Filing · EDGAR
May 28, 2021	Option or RSU exercised or converted Restricted stock units	−1,686	0 direct	Filing · EDGAR
May 20, 2021	Grant or award from the company Restricted stock unit	+1,585	1,585 direct	Filing · EDGAR
May 20, 2021	Grant or award from the company Stock options (right to buy)	+8,888	8,888 direct	Filing · EDGAR
May 29, 2020	Option or RSU exercised or converted	+1,878	3,278 direct	Filing · EDGAR
May 29, 2020	Option or RSU exercised or converted Restricted stock units	−1,878	0 direct	Filing · EDGAR
May 28, 2020	Grant or award from the company Stock options (right to buy)	+8,096	8,096 direct	Filing · EDGAR
May 28, 2020	Grant or award from the company Restricted stock units	+1,686	1,686 direct	Filing · EDGAR
May 31, 2019	Option or RSU exercised or converted	+1,400	1,400 direct	Filing · EDGAR
May 31, 2019	Option or RSU exercised or converted Restricted stock units	−1,400	0 direct	Filing · EDGAR
May 29, 2019	Grant or award from the company Stock option (right to buy)	+8,919	8,919 direct	Filing · EDGAR
May 29, 2019	Grant or award from the company Restricted stock units	+1,878	1,878 direct	Filing · EDGAR
May 31, 2018	Grant or award from the company Stock option (right to buy)	+5,700	5,700 direct	Filing · EDGAR
May 31, 2018	Grant or award from the company Restricted stock units	+1,400	1,400 direct	Filing · EDGAR
Jun 13, 2017	Grant or award from the company Stock option (right to buy)	+8,000	8,000 direct	Filing · EDGAR
Dec 30, 2016	Grant or award from the company Stock option (right to buy)	+16,000	16,000 direct	Filing · EDGAR

Forty Seven Director · filings 2018 to 2020

Date	Transaction	Shares	Held after	Source
Apr 7, 2020	Returned to the company Stock Option (right to buy)	−126,493	0 direct	Filing · EDGAR
Apr 7, 2020	Returned to the company Stock Option (right to buy)	−10,322	0 direct	Filing · EDGAR
Jun 12, 2019	Grant or award from the company Stock Option (right to buy)	+10,322	10,322 direct	Filing · EDGAR

Kite Pharma Director · filings 2017 to 2017

Date	Transaction	Shares	Price	Value	Held after	Source
Oct 3, 2017	Tendered in a change of control	−1,776	$180.00	$320K	5,324 direct	Filing · EDGAR
Oct 3, 2017	Returned to the company	−5,324			0 direct	Filing · EDGAR
Oct 3, 2017	Returned to the company Director Stock Option (Right to Buy)	−17,130	$134.05	$2.3M	0 direct	Filing · EDGAR
Oct 3, 2017	Returned to the company Director Stock Option (Right to Buy)	−8,810	$88.79	$782K	0 direct	Filing · EDGAR
Jun 20, 2017	Grant or award from the company	+2,410			7,100 direct	Filing · EDGAR
Jun 20, 2017	Grant or award from the company Director Stock Option (Right to Buy)	+8,810			8,810 direct	Filing · EDGAR
Jan 3, 2017	Grant or award from the company	+4,690			4,690 direct	Filing · EDGAR
Jan 3, 2017	Grant or award from the company Stock Option (Right to Buy)	+17,130			17,130 direct	Filing · EDGAR

TerraVia Holdings Director · filings 2011 to 2017 · bought $54K

Date	Transaction	Shares	Price	Value	Held after	Source
May 22, 2017	Grant or award from the company Stock Option (right to buy)	+32,000			32,000 direct	Filing · EDGAR
Jun 8, 2016	Grant or award from the company Stock Option (right to buy)	+32,000			32,000 direct	Filing · EDGAR
May 14, 2015	Grant or award from the company Stock Option (right to buy)	+18,000			18,000 direct	Filing · EDGAR
Jan 12, 2015	Grant or award from the company Stock Option (right to buy)	+40,000			40,000 direct	Filing · EDGAR
May 22, 2014	Grant or award from the company Stock Option (right to buy)	+18,000			18,000 direct	Filing · EDGAR
Jun 4, 2013	Grant or award from the company Stock Option (right to buy)	+18,000			18,000 direct	Filing · EDGAR
Sep 19, 2012	Grant or award from the company Stock Option (right to buy)	+18,000			18,000 direct	Filing · EDGAR
Dec 12, 2011	Grant or award from the company Stock Option (Right to Buy)	+33,000			33,000 direct	Filing · EDGAR
Jul 12, 2011	Grant or award from the company Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Jun 2, 2011	Open-market or private purchase	+3,000	$18.00	$54K	3,000 direct	Filing · EDGAR

Dendreon Board of Director · filings 2009 to 2010 · sold $758K

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 20, 2010	Option or RSU exercised or converted	+7,500	$26.64	$200K	7,500 direct	Filing · EDGAR
Aug 20, 2010	Open-market or private sale	−7,500	$37.46	$281K	0 direct	Filing · EDGAR
Aug 20, 2010	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−7,500	$37.46	$281K	0 direct	Filing · EDGAR
May 3, 2010	Open-market or private sale	−8,744	$54.61	$478K	0 direct	Filing · EDGAR
Jan 21, 2010	Grant or award from the company	+3,750			8,744 direct	Filing · EDGAR
Dec 8, 2009	Grant or award from the company Non-Qualified Stock Options (right to buy)	+7,500	$26.64	$200K	7,500 direct	Filing · EDGAR
Oct 7, 2009	Grant or award from the company	+4,994			4,994 direct	Filing · EDGAR

Genentech EVP-commercial · filings 2005 to 2009 · sold $16.1M

Date	Transaction	Shares	Price	Value	Held after	Source
Mar 26, 2009	Returned to the company	−963	$95.00	$91K	0 direct	Filing · EDGAR
Mar 26, 2009	Returned to the company Non-Qualified Stock Option (right to buy)	−5,938			0 direct	Filing · EDGAR
Mar 26, 2009	Returned to the company Non-Qualified Stock Option (right to buy)	−135,000			0 direct	Filing · EDGAR
Mar 26, 2009	Returned to the company Non-Qualified Stock Option (right to buy)	−125,000			0 direct	Filing · EDGAR
Mar 26, 2009	Returned to the company Non-Qualified Stock Option (right to buy)	−125,000			0 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+1,000	$42.05	$42K	1,668 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−1,000	$79.43	$79K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+100	$42.05	$4K	768 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−100	$79.78	$8K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+1,100	$42.05	$46K	1,768 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−1,100	$79.44	$87K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+2,200	$42.05	$93K	2,868 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−2,200	$79.45	$175K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+100	$42.05	$4K	768 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−100	$79.48	$8K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+2,100	$42.05	$88K	2,768 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−2,100	$79.49	$167K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+4,800	$42.05	$202K	5,468 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−4,800	$79.50	$382K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+400	$42.05	$17K	1,068 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−400	$79.51	$32K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+700	$42.05	$29K	1,368 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−700	$79.52	$56K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+200	$42.05	$8K	868 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−200	$79.56	$16K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+1,900	$42.05	$80K	2,568 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−1,900	$79.57	$151K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+619	$42.05	$26K	1,287 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−619	$79.59	$49K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+300	$42.05	$13K	968 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−300	$79.60	$24K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+1,400	$42.05	$59K	2,068 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−1,400	$79.61	$111K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+1,205	$42.05	$51K	1,873 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−1,205	$79.64	$96K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+1,694	$42.05	$71K	2,362 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−1,694	$79.65	$135K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+100	$42.05	$4K	768 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−100	$79.67	$8K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+1,100	$42.05	$46K	1,768 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−1,100	$79.68	$88K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+1,100	$42.05	$46K	1,768 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−1,100	$79.73	$88K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+600	$42.05	$25K	1,268 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−600	$79.74	$48K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+800	$42.05	$34K	1,468 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−800	$79.76	$64K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+100	$42.05	$4K	768 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−100	$79.77	$8K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+3,500	$42.05	$147K	4,168 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−3,500	$79.79	$279K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+100	$42.05	$4K	768 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−100	$79.80	$8K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+1,500	$42.05	$63K	2,168 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−1,500	$79.81	$120K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+113	$42.05	$5K	781 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−113	$79.84	$9K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+900	$42.05	$38K	1,568 direct	Filing · EDGAR
Jul 16, 2008	Open-market or private sale	−900	$79.86	$72K	668 direct	Filing · EDGAR
Jul 16, 2008	Option or RSU exercised or converted	+5,917	$42.05	$249K	6,585 direct	Filing · EDGAR

344 earlier transactions are in the filing list below.

All 159 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Aug 5, 2026	Form 4	Guardant Health GH	Filing · EDGAR
Aug 4, 2026	Form 144	Guardant Health GH	Filing · EDGAR
Jun 23, 2026	Form 4	Olema Pharmaceuticals OLMA	Filing · EDGAR
Jun 22, 2026	Form 4	Guardant Health GH	Filing · EDGAR
Jun 15, 2026	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 4, 2026	Form 4	Biomarin Pharmaceutical BMRN	Filing · EDGAR
May 29, 2026	Form 4	Kyverna Therapeutics KYTX	Filing · EDGAR
May 22, 2026	Form 4	Guardant Health GH	Filing · EDGAR
May 20, 2026	Form 144	Guardant Health GH	Filing · EDGAR
May 13, 2026	Form 144	GoodRx Holdings GDRX	Filing · EDGAR
Mar 18, 2026	Form 3	Takeda Pharmaceutical TAK	Filing · EDGAR
Dec 23, 2025	Form 4	Olema Pharmaceuticals OLMA	Filing · EDGAR
Dec 19, 2025	Form 144	Olema Pharmaceuticals OLMA	Filing · EDGAR
Dec 8, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Dec 5, 2025	Form 144	Guardant Health GH	Filing · EDGAR
Aug 5, 2025	Form 4	Biomarin Pharmaceutical BMRN	Filing · EDGAR
Aug 5, 2025	Form 3	Biomarin Pharmaceutical BMRN	Filing · EDGAR
Jul 9, 2025	Form 4	GoodRx Holdings GDRX	Filing · EDGAR
Jun 20, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Jun 17, 2025	Form 144	Guardant Health GH	Filing · EDGAR
Jun 16, 2025	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 16, 2025	Form 4	Guardant Health GH	Filing · EDGAR
Jun 13, 2025	Form 4	Olema Pharmaceuticals OLMA	Filing · EDGAR
Jun 4, 2025	Form 4	GoodRx Holdings GDRX	Filing · EDGAR
Jun 2, 2025	Form 4	Kyverna Therapeutics KYTX	Filing · EDGAR
Nov 14, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Nov 12, 2024	Form 144	Guardant Health GH	Filing · EDGAR
Jul 10, 2024	Form 4	GoodRx Holdings GDRX	Filing · EDGAR
Jul 10, 2024	Form 3	GoodRx Holdings GDRX	Filing · EDGAR
Jun 18, 2024	Form 4	Olema Pharmaceuticals OLMA	Filing · EDGAR
Jun 17, 2024	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 13, 2024	Form 4	Guardant Health GH	Filing · EDGAR
Feb 7, 2024	Form 3	Kyverna Therapeutics KYTX	Filing · EDGAR
Dec 8, 2023	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 21, 2023	Form 4	Olema Pharmaceuticals OLMA	Filing · EDGAR
Jun 20, 2023	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 16, 2023	Form 4	Guardant Health GH	Filing · EDGAR
Jun 8, 2023	Form 4	AVROBIO	Filing · EDGAR
Aug 15, 2022	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 27, 2022	Form 4/A	Olema Pharmaceuticals OLMA	Filing · EDGAR
Jun 17, 2022	Form 4	Guardant Health GH	Filing · EDGAR
Jun 17, 2022	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 17, 2022	Form 4	Olema Pharmaceuticals OLMA	Filing · EDGAR
Jun 10, 2022	Form 4	AVROBIO	Filing · EDGAR
May 24, 2022	Form 4	Agios Pharmaceuticals	Filing · EDGAR
Sep 13, 2021	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Sep 3, 2021	Form 4	Guardant Health GH	Filing · EDGAR
Jul 1, 2021	Form 4	Guardant Health GH	Filing · EDGAR
Jun 21, 2021	Form 4	Guardant Health GH	Filing · EDGAR
Jun 16, 2021	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 14, 2021	Form 4	AVROBIO	Filing · EDGAR
Jun 10, 2021	Form 4	Olema Pharmaceuticals OLMA	Filing · EDGAR
Jun 2, 2021	Form 4	Agios Pharmaceuticals	Filing · EDGAR
May 24, 2021	Form 4	Agios Pharmaceuticals	Filing · EDGAR
Apr 28, 2021	Form 4	Guardant Health GH	Filing · EDGAR
Mar 29, 2021	Form 4	Guardant Health GH	Filing · EDGAR
Mar 1, 2021	Form 4	Guardant Health GH	Filing · EDGAR
Jan 27, 2021	Form 4	Guardant Health GH	Filing · EDGAR
Jan 6, 2021	Form 4	Guardant Health GH	Filing · EDGAR
Dec 30, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Dec 7, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Nov 27, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Nov 19, 2020	Form 4	Olema Pharmaceuticals OLMA	Filing · EDGAR
Nov 18, 2020	Form 3	Olema Pharmaceuticals OLMA	Filing · EDGAR
Nov 5, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Oct 28, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Oct 5, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Sep 10, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Jun 29, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Jun 16, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Jun 12, 2020	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 5, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Jun 5, 2020	Form 4	AVROBIO	Filing · EDGAR
Jun 1, 2020	Form 4	Agios Pharmaceuticals	Filing · EDGAR
May 26, 2020	Form 4	Guardant Health GH	Filing · EDGAR
May 6, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Apr 29, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Apr 16, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Apr 7, 2020	Form 4	Forty Seven	Filing · EDGAR
Mar 27, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Mar 23, 2020	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Mar 4, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Feb 27, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Feb 5, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Jan 29, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Jan 7, 2020	Form 4	Guardant Health GH	Filing · EDGAR
Dec 30, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Dec 5, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Nov 27, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Nov 6, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Oct 29, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Sep 27, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Sep 5, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Aug 28, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Aug 8, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Jun 24, 2019	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 20, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Jun 14, 2019	Form 4	Forty Seven	Filing · EDGAR
Jun 13, 2019	Form 4	AVROBIO	Filing · EDGAR
May 31, 2019	Form 4	Agios Pharmaceuticals	Filing · EDGAR
May 3, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Apr 29, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Apr 17, 2019	Form 4	Guardant Health GH	Filing · EDGAR
Oct 3, 2018	Form 3	Guardant Health GH	Filing · EDGAR
Jun 27, 2018	Form 3	Forty Seven	Filing · EDGAR
Jun 25, 2018	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 20, 2018	Form 3	AVROBIO	Filing · EDGAR
Jun 4, 2018	Form 4	Agios Pharmaceuticals	Filing · EDGAR
Oct 5, 2017	Form 4	Kite Pharma	Filing · EDGAR
Jun 22, 2017	Form 4	Kite Pharma	Filing · EDGAR
Jun 15, 2017	Form 4	Agios Pharmaceuticals	Filing · EDGAR
Jun 9, 2017	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
May 23, 2017	Form 4	TerraVia Holdings	Filing · EDGAR
Jan 5, 2017	Form 4	Kite Pharma	Filing · EDGAR
Jan 5, 2017	Form 3	Kite Pharma	Filing · EDGAR
Jan 4, 2017	Form 4	Agios Pharmaceuticals	Filing · EDGAR
Jan 4, 2017	Form 3	Agios Pharmaceuticals	Filing · EDGAR
Jan 4, 2017	Form 4	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jan 4, 2017	Form 3	Corvus Pharmaceuticals CRVS	Filing · EDGAR
Jun 10, 2016	Form 4	TerraVia Holdings	Filing · EDGAR
May 14, 2015	Form 4	TerraVia Holdings	Filing · EDGAR
Jan 14, 2015	Form 4	TerraVia Holdings	Filing · EDGAR
May 27, 2014	Form 4	TerraVia Holdings	Filing · EDGAR
Jun 6, 2013	Form 4	TerraVia Holdings	Filing · EDGAR
Sep 20, 2012	Form 4	TerraVia Holdings	Filing · EDGAR
Dec 14, 2011	Form 4	TerraVia Holdings	Filing · EDGAR
Jul 12, 2011	Form 4	TerraVia Holdings	Filing · EDGAR
Jun 3, 2011	Form 4	TerraVia Holdings	Filing · EDGAR
May 26, 2011	Form 3	TerraVia Holdings	Filing · EDGAR
Aug 23, 2010	Form 4	Dendreon	Filing · EDGAR
May 6, 2010	Form 4	Dendreon	Filing · EDGAR
Jan 25, 2010	Form 4	Dendreon	Filing · EDGAR
Dec 10, 2009	Form 4	Dendreon	Filing · EDGAR
Oct 9, 2009	Form 4	Dendreon	Filing · EDGAR
Oct 9, 2009	Form 3	Dendreon	Filing · EDGAR
Mar 31, 2009	Form 4	Genentech	Filing · EDGAR
Jul 18, 2008	Form 4	Genentech	Filing · EDGAR
Jul 18, 2008	Form 4	Genentech	Filing · EDGAR
Jul 18, 2008	Form 4	Genentech	Filing · EDGAR
Jul 18, 2008	Form 4	Genentech	Filing · EDGAR
Jul 18, 2008	Form 4	Genentech	Filing · EDGAR
Jul 18, 2008	Form 4	Genentech	Filing · EDGAR
Jul 18, 2008	Form 4	Genentech	Filing · EDGAR
Feb 29, 2008	Form 4	Genentech	Filing · EDGAR
Sep 24, 2007	Form 4	Genentech	Filing · EDGAR
Jan 22, 2007	Form 4	Genentech	Filing · EDGAR
Jan 19, 2007	Form 4	Genentech	Filing · EDGAR
Jan 18, 2007	Form 4	Genentech	Filing · EDGAR
Jan 17, 2007	Form 4	Genentech	Filing · EDGAR
Jan 17, 2007	Form 4	Genentech	Filing · EDGAR
Sep 22, 2006	Form 4	Genentech	Filing · EDGAR
Nov 28, 2005	Form 4	Genentech	Filing · EDGAR
Nov 16, 2005	Form 4	Genentech	Filing · EDGAR
Nov 15, 2005	Form 4	Genentech	Filing · EDGAR
Nov 14, 2005	Form 4	Genentech	Filing · EDGAR
Nov 4, 2005	Form 4	Genentech	Filing · EDGAR
Sep 27, 2005	Form 4	Genentech	Filing · EDGAR
Aug 23, 2005	Form 4	Genentech	Filing · EDGAR
Aug 22, 2005	Form 3	Genentech	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 7, 2026, 1:08 AM ET. The filing on SEC.gov is the record.